MD Anderson Research Highlights: ASCO 2024 Special Edition
May 24, 2024
May 24, 2024
HOUSTON, Texas, May 24 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following research highlight:
* * *
Featuring clinical trial results for leptomeningeal metastases, lymphoma and melanoma, biomarkers for anal cancer recurrence, and immunotherapy to prevent oral cancer
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, researc . . .
* * *
Featuring clinical trial results for leptomeningeal metastases, lymphoma and melanoma, biomarkers for anal cancer recurrence, and immunotherapy to prevent oral cancer
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, researc . . .